Citadel Advisors
AFIB

Citadel Advisors’s Acutus Medical Inc AFIB Stock Holding History

Citadel Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300
Closed -$61 – 15699
2023
Q4 		$61 Buy
+300
New +$118 ﹤0.01% 14145
2023
Q3 		– Sell
-100
Closed -$89 – 15381
2023
Q2 		$89 Sell
100
-1,900
-95% -$1.61K ﹤0.01% 14226
2023
Q1 		$1.51K Sell
2,000
-2,900
-59% -$3.78K ﹤0.01% 14290
2022
Q4 		$5.63K Buy
+4,900
New +$4.04K ﹤0.01% 13982
2021
Q4 		– Sell
-20,200
Closed -$179K – 15033
2021
Q3 		$179K Buy
20,200
+9,600
+91% +$126K ﹤0.01% 12143
2021
Q2 		$180K Buy
+10,600
New +$155K ﹤0.01% 12286

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's AFIB Position: Q1 2024 in Review

Citadel Advisors sold out of Acutus Medical Inc (AFIB) in Q1 2024, closing a stake of 107,673 shares — an estimated $21.7K sold.

Citadel Advisors first reported a position in AFIB in Q3 2020 and held it in 10 quarters. The position peaked at $2.82M in Q3 2020. 23 funds tracked by Wall St. Rank hold AFIB as of Q1 2024.

  • Citadel Advisors reported no remaining Acutus Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 107,673 Acutus Medical Inc shares in Q1 2024, an estimated $21.7K.
  • Citadel Advisors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Acutus Medical Inc position peaked at $2.82M in Q3 2020.
  • 23 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.